Olivier Dupuis
Overview
Explore the profile of Olivier Dupuis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Du K, Septans A, Domont J, Dupuis O, Emmanuel E, Peribois A, et al.
Oncol Res Treat
. 2024 May;
47(7-8):331-339.
PMID: 38714181
Introduction: The incidence of anaemia and its consequences are often underestimated during cancer management. We propose to evaluate the situation before and after the recommendations were updated in order to...
2.
Le Du K, Septans A, Maloisel F, Vanquaethem H, Schmitt A, Le Goff M, et al.
J Med Internet Res
. 2023 Feb;
25:e38619.
PMID: 36790852
Background: Evidence regarding the analgesic effect of distraction through immersion in virtual reality (VR) for care-induced pain has been documented in several phase 2 trials, but comparison with standard treatments...
3.
Delagrange L, Dupuis O, Fargeton A, Bernard L, Decullier E, Dupuis-Girod S
BJOG
. 2022 Sep;
130(3):303-311.
PMID: 36156839
Objective: To retrospectively describe a large series of pregnancies in women with hereditary haemorrhagic telangiectasia followed in our reference centre, plus neonatal outcomes, to better understand the risks of complications...
4.
Metges J, Douillard J, Ramee J, Dupuis O, Senellart H, Porneuf M, et al.
Turk J Gastroenterol
. 2020 Nov;
31(10):695-705.
PMID: 33169707
Background/aims: The Bretagne-Pays de la Loire cancer observatory, an oncology network created by the French Ministry of Health, is specifically dedicated to assess the use of new targeted anticancer therapies...
5.
Eker O, Boccardi E, Sure U, Patel M, Alicante S, Alsafi A, et al.
Orphanet J Rare Dis
. 2020 Jul;
15(1):165.
PMID: 32600364
Hereditary haemorrhagic telangiectasia (HHT) is a multisystemic vascular dysplasia inherited as an autosomal dominant trait. Approximately 10 % of patients have cerebral vascular malformations, a proportion being cerebral arteriovenous malformations...
6.
Delattre J, Cohen R, Henriques J, Falcoz A, Emile J, Fratte S, et al.
J Clin Oncol
. 2020 Mar;
38(15):1702-1710.
PMID: 32167864
Patients And Methods: A post hoc analysis of all pathologic reports from patients with stage III CC included in the IDEA France phase III study (ClinicalTrials.gov identifier: NCT00958737) investigating the...
7.
Dupuis O, Delagrange L, Dupuis-Girod S
Orphanet J Rare Dis
. 2020 Jan;
15(1):5.
PMID: 31910869
Background: Hereditary haemorrhagic telangiectasia (HHT) is a dominantly inherited genetic vascular disorder that has prevalence of 1:5000 to 1:8000, and which is characterised by recurrent epistaxis, cutaneous telangiectasia, and arteriovenous...
8.
Chauleur C, Gris J, Laporte S, Chapelle C, Bertoletti L, Equy V, et al.
Thromb Haemost
. 2018 Aug;
118(9):1564-1571.
PMID: 30103244
Background: Management of pregnant women at risk of venous thromboembolism (VTE) and placental vascular complications (PVCs) remains complex. Guidelines do not definitively specify optimal strategies. Objective: Our objective was to...
9.
Andre T, Vernerey D, Mineur L, Bennouna J, Desrame J, Faroux R, et al.
J Clin Oncol
. 2018 Apr;
36(15):1469-1477.
PMID: 29620995
Purpose Reduction of adjuvant treatment duration may decrease toxicities without loss of efficacy in stage III colon cancer. This could offer clear advantages to patients and health care providers. Methods...
10.
Peyraga G, Caron D, Lizee T, Metayer Y, Septans A, Pointreau Y, et al.
Support Care Cancer
. 2017 Dec;
26(6):1897-1903.
PMID: 29275524
Objective: The palliative treatment for cervico-thoracic spinal metastases is based on a three-dimensional conformal radiation therapy (3D-CRT). Digestive toxicities are common and cause a clinical impact frequently underestimated in patients....